Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Mingren Shikang Technology develops, manufactures, and sells ophthalmic medical devices—primarily red light therapy equipment—for the treatment of myopia and amblyopia. Their products have been commercialized in China as Class II medical devices. Clinical studies suggest efficacy in slowing myopic progression, but there are ongoing concerns about long-term safety due to insufficient data on retinal effects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Mingren Shikang Technology.